These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31606544)
1. Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor. Zhao L; Tang B; Tang P; Sun Q; Suo Z; Zhang M; Gan N; Yang H; Li H J Pharm Sci; 2020 Feb; 109(2):1136-1144. PubMed ID: 31606544 [TBL] [Abstract][Full Text] [Related]
2. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Elmoghayer ME; Saleh NM; Abu Hashim II Drug Deliv Transl Res; 2024 Apr; 14(4):895-917. PubMed ID: 37843733 [TBL] [Abstract][Full Text] [Related]
3. Dimethyl-β-cyclodextrin/salazosulfapyridine inclusion complex-loaded chitosan nanoparticles for sustained release. Tang P; Yang H; Tang B; Wu D; Du Q; Xu K; Li H Carbohydr Polym; 2017 Jan; 156():215-222. PubMed ID: 27842816 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of naringenin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for ocular drug delivery. Zhang P; Liu X; Hu W; Bai Y; Zhang L Carbohydr Polym; 2016 Sep; 149():224-30. PubMed ID: 27261746 [TBL] [Abstract][Full Text] [Related]
5. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol. Deng F; Hu W; Chen H; Tang Y; Zhang L Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869 [TBL] [Abstract][Full Text] [Related]
6. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666 [TBL] [Abstract][Full Text] [Related]
7. Chitosan/sulfobutylether-β-cyclodextrin based nanoparticles coated with thiolated hyaluronic acid for indomethacin ophthalmic delivery. Ricci F; Racaniello GF; Lopedota A; Laquintana V; Arduino I; Lopalco A; Cutrignelli A; Franco M; Sigurdsson HH; Denora N Int J Pharm; 2022 Jun; 622():121905. PubMed ID: 35697201 [TBL] [Abstract][Full Text] [Related]
8. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Mahmoud AA; El-Feky GS; Kamel R; Awad GE Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097 [TBL] [Abstract][Full Text] [Related]
9. Sulfobutylether-β-cyclodextrin/chitosan nanoparticles enhance the oral permeability and bioavailability of docetaxel. Wu J; Shen Q; Fang L Drug Dev Ind Pharm; 2013 Jul; 39(7):1010-9. PubMed ID: 22681515 [TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293 [TBL] [Abstract][Full Text] [Related]
12. Preparation of Doxorubicin-Loaded Carboxymethyl-β-Cyclodextrin/Chitosan Nanoparticles with Antioxidant, Antitumor Activities and pH-Sensitive Release. Mi Y; Zhang J; Tan W; Miao Q; Li Q; Guo Z Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621929 [TBL] [Abstract][Full Text] [Related]
13. Sulfobutylether-β-cyclodextrin/chitosan nano- and microparticles and their physicochemical characteristics. Fülöp Z; Saokham P; Loftsson T Int J Pharm; 2014 Sep; 472(1-2):282-7. PubMed ID: 24971695 [TBL] [Abstract][Full Text] [Related]
14. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles. Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Wang X; Chen C; Huo D; Qian H; Ding Y; Hu Y; Jiang X Carbohydr Polym; 2012 Sep; 90(1):361-9. PubMed ID: 24751053 [TBL] [Abstract][Full Text] [Related]
16. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery. Rukmangathen R; Yallamalli IM; Yalavarthi PR Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571 [No Abstract] [Full Text] [Related]
17. Mesalazine/hydroxypropyl-β-cyclodextrin/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity. Tang P; Sun Q; Zhao L; Pu H; Yang H; Zhang S; Gan R; Gan N; Li H Carbohydr Polym; 2018 Oct; 198():418-425. PubMed ID: 30093018 [TBL] [Abstract][Full Text] [Related]
18. Design, Optimization, and Characterization of Lactoferrin-Loaded Chitosan/TPP and Chitosan/Sulfobutylether-β-cyclodextrin Nanoparticles as a Pharmacological Alternative for Keratoconus Treatment. Varela-Fernández R; García-Otero X; Díaz-Tomé V; Regueiro U; López-López M; González-Barcia M; Lema MI; Otero-Espinar FJ ACS Appl Mater Interfaces; 2021 Jan; 13(3):3559-3575. PubMed ID: 33428398 [TBL] [Abstract][Full Text] [Related]
19. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
20. Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment. Mumuni MA; Kenechukwu FC; Ofokansi KC; Attama AA; Díaz DD Carbohydr Polym; 2020 Feb; 229():115506. PubMed ID: 31826394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]